Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
42.75
Dollar change
+0.05
Percentage change
0.12
%
Index- P/E28.02 EPS (ttm)1.53 Insider Own0.46% Shs Outstand226.45M Perf Week-2.73%
Market Cap9.46B Forward P/E18.56 EPS next Y2.30 Insider Trans0.00% Shs Float220.34M Perf Month-1.70%
Income341.30M PEG16.88 EPS next Q0.44 Inst Own59.41% Short Float1.49% Perf Quarter-1.62%
Sales1.97B P/S4.82 EPS this Y0.61% Inst Trans0.60% Short Ratio2.63 Perf Half Y7.94%
Book/sh16.81 P/B2.54 EPS next Y9.56% ROA5.50% Short Interest3.29M Perf Year-7.83%
Cash/sh4.78 P/C8.95 EPS next 5Y1.66% ROE9.38% 52W Range34.74 - 47.69 Perf YTD-1.55%
Dividend Est.- P/FCF30.55 EPS past 5Y12.66% ROI7.10% 52W High-10.36% Beta0.41
Dividend TTM- Quick Ratio1.62 Sales past 5Y6.29% Gross Margin62.23% 52W Low23.07% ATR (14)0.64
Dividend Ex-DateJan 30, 2024 Current Ratio1.99 EPS Y/Y TTM-19.54% Oper. Margin22.66% RSI (14)38.49 Volatility1.37% 1.31%
Employees5967 Debt/Eq0.42 Sales Y/Y TTM-8.23% Profit Margin17.37% Recom1.91 Target Price51.16
Option/ShortYes / Yes LT Debt/Eq0.26 EPS Q/Q9.76% Payout0.00% Rel Volume0.81 Prev Close42.70
Sales Surprise1.64% EPS Surprise-0.18% Sales Q/Q2.24% EarningsFeb 06 AMC Avg Volume1.25M Price42.75
SMA20-2.56% SMA50-2.46% SMA200-0.23% Trades Volume1,012,975 Change0.12%
Date Action Analyst Rating Change Price Target Change
Dec-19-23Initiated Wells Fargo Equal Weight $44
Dec-13-23Initiated Wolfe Research Peer Perform
Dec-07-23Upgrade Goldman Neutral → Buy $50
Sep-12-23Initiated Robert W. Baird Outperform $50
May-23-23Upgrade Morgan Stanley Equal-Weight → Overweight
Oct-18-22Initiated Morgan Stanley Equal-Weight
Jan-18-22Upgrade DZ Bank Hold → Buy
Oct-15-21Resumed Cowen Market Perform $55
Oct-14-21Initiated Redburn Buy
Jul-14-21Downgrade Kepler Buy → Hold $49.53
Mar-26-24 10:07AM
Mar-25-24 04:05PM
09:10AM
Mar-18-24 04:05PM
Mar-11-24 05:59AM
11:31AM Loading…
Mar-07-24 11:31AM
Mar-04-24 08:39AM
Feb-27-24 05:44PM
04:05PM
Feb-19-24 09:09AM
Feb-15-24 04:05PM
Feb-13-24 08:26AM
Feb-07-24 11:54AM
07:20AM
Feb-06-24 08:00PM
05:42PM Loading…
05:42PM
04:05PM
Jan-31-24 07:35AM
Jan-25-24 10:00AM
Jan-18-24 04:05PM
Jan-12-24 08:37AM
Jan-11-24 07:53AM
Jan-09-24 10:54AM
Jan-08-24 02:00AM
Jan-07-24 01:07PM
Jan-04-24 04:05PM
Jan-03-24 02:00AM
Dec-28-23 07:25AM
Dec-13-23 12:19PM
Nov-30-23 04:05PM
11:30AM Loading…
Nov-29-23 11:30AM
Nov-16-23 09:58AM
Nov-15-23 04:05PM
06:32AM
Nov-09-23 04:05PM
Nov-07-23 07:01AM
Nov-06-23 04:05PM
08:35AM
Nov-02-23 08:00AM
Nov-01-23 12:26PM
Oct-31-23 11:41AM
07:37AM
Oct-30-23 07:30PM
06:40PM
05:27PM
04:05PM
Oct-26-23 08:00AM
Oct-24-23 10:00AM
Oct-23-23 10:00AM
Oct-18-23 10:59AM
Oct-09-23 11:56AM
11:14AM
Oct-05-23 09:51AM
Oct-04-23 04:05PM
Oct-02-23 11:35AM
09:14AM
Sep-28-23 04:05PM
07:52AM
Sep-27-23 04:05PM
Sep-26-23 08:44AM
Sep-25-23 04:05PM
Sep-24-23 10:30AM
Sep-12-23 10:08AM
Sep-07-23 11:30AM
Aug-09-23 10:24AM
08:21AM
Aug-08-23 06:05PM
05:02PM
04:05PM
12:48PM
Aug-07-23 04:05PM
02:03PM
Jul-26-23 04:15PM
Jul-24-23 07:41AM
Jul-20-23 09:16AM
Jul-19-23 10:01AM
Jul-18-23 04:05PM
10:01AM
Jul-12-23 12:23PM
Jul-07-23 11:40AM
Jun-26-23 11:23AM
Jun-21-23 12:50PM
Jun-20-23 04:05PM
Jun-16-23 11:55AM
07:36AM
Jun-15-23 04:05PM
Jun-14-23 11:48AM
Jun-13-23 04:05PM
Jun-02-23 11:31AM
May-23-23 11:01AM
May-19-23 08:05AM
May-04-23 02:38PM
08:27AM
May-03-23 07:25PM
06:19PM
04:05PM
05:30AM
Apr-28-23 12:10PM
09:55AM
Apr-24-23 04:05PM
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.